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Abstract
It has previously been shown that the 5 untranslated leader region (UTR), including about 495 bp of the gag gene, is sufficient for the
efficient encapsidation and propagation of Mason–Pfizer monkey virus (MPMV) based retroviral vectors. In addition, a deletion upstream
of the major splice donor, SD, has been shown to adversely affect MPMV RNA packaging. However, the precise sequence requirement for
the encapsidation of MPMV genomic RNA within the 5 UTR and gag remains largely unknown. In this study, we have used a systematic
deletion analysis of the 5 UTR and gag gene to define the cis-acting sequences responsible for efficient MPMV RNA packaging. Using
an in vivo packaging and transduction assay, our results reveal that the MPMV packaging signal is primarily found within the first 30 bp
immediately downstream of the primer binding site. However, its function is dependent upon the presence of the last 23 bp of the 5 UTR
and approximately the first 100 bp of the gag gene. Thus, sequences that affect MPMV RNA packaging seem to reside both upstream and
downstream of the major splice donor with the downstream region responsible for the efficient functioning of the upstream primary
packaging determinant.
© 2003 Elsevier Science (USA). All rights reserved.
Keywords: Retroviruses; RNA; Beta retroviruses; Packaging; Type D; Encapsidation; MPMV; Packaging signal; Retroviral vectors; Transduction
Introduction
Viral genomic RNA encapsidation or packaging into
retroviral particles is of interest because of its role in the
study of the retrovirus life cycle as well as for the develop-
ment of retroviral vectors. Retroviruses contain two copies
of single-stranded RNA genome in each virion (reviewed in
Swanstrom and Wills, 1997). These RNA genomes, which
are non-covalently dimerized, must be recognized by the
proteins of the assembling virion. Packaging of the viral
genomic RNA is highly specific to ensure that only the
full-length, unspliced RNA is packaged as opposed to
spliced viral or cellular mRNAs. This specificity is deter-
mined by the interaction of the viral Gag polyprotein and
cis-acting sequences in the viral genomic RNA such as the
packaging signal ().
The Gag polyprotein, specifically the nucleocapsid (NC)
region, is responsible for recognition of the viral genomic
RNA (reviewed in Lever, 2000). The nucleocapsid region,
which is cleaved into a separate protein upon maturation,
possesses zinc finger-like domains, which are the critical
elements for the recognition of the viral packaging signal
(De Guzman et al., 1998; Lee et al., 1998). Indeed, muta-
tions of these domains may lead to an abolishment of RNA
packaging.
The second component of packaging, , is located in the
5 region of the RNA and usually encompasses sequences
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between the 5 untranslated region (UTR)1 and the start of
the Gag open reading frame (ORF) (reviewed in Lever,
2000; Linial and Miller, 1990). These sequences typically
form secondary RNA structures in the form of stem loops.
It is these stem loops and the primary sequence within
them that interact with the NC region of the Gag polypro-
tein to confer specific viral RNA packaging. In addition,
the 5 major splice donor (SD) is often near the  and may
help the virion to preferentially select full-length unspliced
viral RNA over spliced viral mRNA (Kaye and Lever,
1999).
The packaging signals of the alpha () retroviruses such
as Rous sarcoma virus (RSV), gamma () retroviruses such
as murine leukemia virus (MLV), and lentiviruses such as
human immunodeficiency virus (HIV) have been studied
extensively (Adam and Miller, 1988; Arnoff et al., 1993;
Banks et al., 1998; Banks and Linial, 2000; Bender et al.,
1987; Katz et al., 1986; Lever, 2000; Linial and Miller, 19
90; Mann et al., 1983; McBride and Panganiban, 1996,
1997; Rizvi and Panganiban, 1993; Watanabe and Temin,
1982 and references therein). Information gleaned from
these studies has allowed the generation of retroviral vectors
that have subsequently been used to define various aspects
of retroviral life cycle such as the identification of retroviral
receptors (Albritton et al., 1989; Takeuchi et al., 1992),
strand switching during reverse transcription (Panganiban
and Fiore, 1988), intracellular transport of viral RNAs
(Rizvi et al., 1996a, b, 1997), etc., as well as vectors for
gene delivery into target cells (Akkina et al., 1996; Mitra-
phanous et al., 1999; Rosenberg et al., 1990). Study of the
packaging determinant of retroviruses has revealed that typ-
ically the  of  and  retroviruses lies downstream of the
primer binding site (PBS) and often contains a portion of
gag gene (Linial and Miller, 1990). For these retroviruses,
the packaging signal seems to be discrete and well-defined;
however, in the case of the complex retroviruses such as
HIV-1, HIV-2, and bovine and human T cell leukemia
viruses (BLV/HTLV), the packaging signal seems to be
spread out and multipartite (Mansky and Wisniewski, 1998;
McBride and Panganiban, 1996; McCann and Lever, 1997;
reviewed in Lever, 2000).
In contrast to these viruses, limited research has been
done on delineating the sequences responsible for packag-
ing of the beta () retroviruses. -Retroviruses include
viruses that display either type-B or type-D morphology
during the assembly and maturation stages of virus replica-
tion, such as mouse mammary tumor virus (MMTV), Ma-
son–Pfizer monkey virus (MPMV), and simian retroviruses
(SRV). Viral vectors based on -retroviruses are being
developed to study basic steps in virus replication unique to
these viruses (Guesdon et al., 2001; Gunzberg et al., 1995;
Li et al., 2001). In addition, such vectors may turn out to be
valuable for gene therapy as well since these viruses have
their own characteristics which may provide better alterna-
tives to the existing retroviral vectors which are based on
oncogenic retroviruses such as MLV or lentiviruses such as
HIV (Temin, 1989). This is especially true since we have
shown earlier that even phylogenetically more distantly
related lentiviruses such as HIV and simian immunodefi-
ciency virus (SIV) and feline immunodeficiency virus (FIV)
can cross-package each other’s genomic RNAs and propa-
gate the RNAs for further steps in viral life cycle (Browning
et al., 2001). However, a nonlentivirus similar to MPMV
cannot package or propagate lentiviral RNAs even though it
may be a primate retrovirus (Browning et al., 2001).
MPMV is a classical type-D retrovirus that causes an
immunodeficiency syndrome in newborn rhesus monkeys
(Bryant et al., 1986; Fine et al., 1975). Retroviruses very
similar to MPMV that also cause AIDS in primates have
been characterized such as SRV-1 and -2 (Daniel et al.,
1984; Desrosiers et al., 1985; Marx et al., 1984). Among the
-retroviruses, MPMV is perhaps the most well-studied in
terms of packaging and transduction. In one of the earliest
such studies, a 624-bp region downstream of the PBS was
shown to confer efficient packaging on MPMV-based ret-
roviral vectors (Vile et al., 1992). Using biochemical prob-
ing, free-energy estimations, and phylogenetic analyses,
part of this region (the first 275 bases) was later shown to
assume a higher order complex structure composed of eight
stem loops (Harrison et al., 1995). A further limited deletion
analysis of the 5 UTR of MPMV genome has shown that
removal of a small 61-bp region upstream of the major
splice donor reduces packaging efficiency of a replication-
competent virus to 58% of the wild-type (Guesdon et al.,
2001). Along the same lines, the packaging signal of a
similar serogroup 2 -retrovirus, SRV-2, has been mapped
to a considerable 305-bp region at the 5 end of the viral
genome (Li et al., 2001). This region contains the last 149
bp of the 5 UTR and first 156 bp immediately downstream
of the gag ATG. However, no systematic study of the 5 end
of the viral genome has been performed to characterize the
nature of the packaging signal that exists within MPMV or
the relative contribution of sequences with the 5 UTR and
gag toward encapsidation.
In this study, we performed a detailed deletion analysis
of the 5 UTR and the gag gene of MPMV to delineate the
minimum sequences responsible for efficient RNA packag-
ing. Our results reveal that the packaging determinants of
MPMV are complex. The primary packaging determinant
exists immediately downstream of the PBS, but its efficient
function is dependent upon the existence of a secondary
determinant located within the 5 UTR and gag boundary.
Thus, similar to complex retroviruses, MPMV packaging
signal seems to be discontinuous, yet interdependent, with
sequences important in packaging found both upstream and
downstream of the major SD.
1 Abbreviations used: CFU, colony forming units; CTE, constitutive
transport element; Hygr, hygromycin resistant colonies; LTR, long termi-
nal repeat; ORF, open reading frame; PBS, primer binding site; PPT,
polypurine tract; SD, splice donor; SV-40, simian virus type 40; UTR,
untranslated region; VSV-G, vesicular stomatitis virus glycoprotein.
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Results
Design and construction of the in vivo packaging and
transduction assay
To map the MPMV sequences involved in efficient pack-
aging, we used our previously developed in vivo packaging
and transduction assay that was used to study cross-pack-
aging among retroviruses (Browning et al., 2001). This
assay consisted of a packaging construct, TR301, which
expresses the MPMV Gag/Pol proteins from the human
cytomegalovirus (hCMV) promoter (Fig. 1A). Since TR301
lacks the packaging signal, RNA expressed from TR301
cannot be packaged into nascent virions. MD.G, the enve-
lope expression vector, provided the second structural com-
ponent in this assay from the vesicular stomatitis virus
(VSV) (Fig. 1B). The envelope glycoprotein of VSV
(VSV-G) was expressed from the hCMV promoter and
allowed the newly formed virions to infect the target cells
efficiently, enabling the study of steps involved in packag-
ing and propagation of the transfer vector RNAs. The pack-
aging substrate in this assay was provided by KAL011, a
vector that contains the entire 5 MPMV UTR (128 bp) as
well as 284 bp of gag (Fig. 1C). In addition, it expresses the
hygromycin resistance gene from the SV40 promoter (SV-
Hygr) as a marker for successful transduction into the target
cells. KAL011 can be efficiently packaged and propagated
by MPMV proteins in the trans-complementation assay
(Browning et al., 2001).
The in vivo packaging and transduction assay allowed
the biological testing of mutations introduced into the trans-
fer vectors since the defective nature of the virions produced
limited the assay to a single round of replication only. Thus,
the number of Hygr colonies observed in this assay corre-
lated directly with the packaging efficiency of the transfer
vector RNA unless other sequences involved in vector RNA
propagation were affected by these mutations, such as steps
involved in reverse transcription and integration. To ensure
Fig. 1. Components of the MPMV in vivo packaging and transduction assay. (A) MPMV genome followed by the MPMV packaging construct, TR301. (B)
The vesicular stomatitis virus (VSV) envelope glycoprotein (G) expression construct, MD.G, used to pseudotype virions expressed by TR301 containing the
transfer vector RNA. (C) MPMV-based transfer vector, KAL011, used to generate the deletion mutants used in this study. CMV, cytomegalovirus
promoter/enhancer; , packaging signal; SD, splice donor; SV, simian virus 40 early promoter; hygr, hygromycin B phosphotransferase gene; CTE,
constitutive transport element from MPMV.
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that effects of the mutations on packaging were being
scored, we also analyzed the amount of RNA packaged by
the nascently produced virions directly.
The first 15 bp downstream of the PBS and the last 23 bp
of the MPMV 5 UTR are important for efficient RNA
packaging
To determine the role of MPMV sequences in packaging
within the 5 UTR, we modified KAL011 to create a series
of transfer vectors that contained varying amounts of the 5
UTR in the presence of 284 bp of gag (Fig. 2A). TR302
contains only the PBS, while each consecutive vector there-
after contained increasing amounts of the 5 UTR in 15 bp
increments from the PBS until 105 bp in TR309. TR302–
309 were tested in the in vivo packaging and transduction
assay for the ability of transfer vector RNAs to be packaged
and propagated by the MPMV proteins. This was accom-
plished by cotransfection of each of the transfer vectors
along with the packaging construct, TR301, and the VSV-G
Env expression vector, MD.G., into African green monkey
kidney Cos cells. Virus was isolated 3 days posttransfection
and processed for virions RNA and proteins, as well as used
to infect the HeLa CD4 target cells. The transfected Cos
cells were processed for intracellular transfer vector RNA,
while the infected target cells were selected with hygromy-
cin B to distinguish successfully transduced cells by the
appearance of hygromycin resistant colonies (Hygr) 10 days
postinfection.
As a first step, we analyzed the relative levels of virions
produced in each of the transfected cultures. Western blot
analysis of virions purified from the supernatants of the
transfected cultures revealed that similar levels of virions
were produced in each of the transfected cultures (Fig. 2B,
panel IV). Next, we analyzed the amount of RNA packaged
by these virions using slot blot analysis and a radiolabeled
hygromycin gene fragment as the probe (Fig. 2B, panel III).
To control for RNA loading, diluted RNAs from transfected
Cos cells were analyzed by slot blots using a radiolabeled
-actin probe (Fig. 2B, panel I). In parallel, a duplicate blot
of cellular RNA was probed with radiolabeled hygromycin
gene fragment to analyze the stability and steady-state lev-
els of transfer vector RNAs and to estimate the transfection
efficiencies (Fig. 2B, panel II). Optical densities observed in
each of the slot blots were quantitated using a density
analysis software, and values obtained from the analysis of
RNA packaged into virions were then normalized to those
obtained from cellular RNAs (see Materials and methods
for details). After normalization, these analyses revealed
that lack of the last 23 bp of the 5 UTR had an adverse
effect on RNA packaging, leading to a 6.1-fold loss in
packaging efficiency compared to the control vector,
KAL011 (see TR309, Fig. 2B, panel III). The packaging
efficiency remained essentially similar for the next five
transfer vectors that shortened the 5 UTR from 105 to 15
bp (TR307–303). However, deletion of 15 bp of the 5 UTR
immediately following the PBS lead to an additional 2.5- to
4-fold decrease in vector RNA packaging compared to
TR307–303. Relative to KAL011, this represented a 10-fold
reduction in packaging efficiency (see TR302, Fig. 2B,
panel III). These data reveal that the first 15 bp of the 5
UTR just downstream from the PBS and the last 23 bp are
important for efficient MPMV RNA packaging, while se-
quences in between these extremes do not affect MPMV
RNA packaging significantly.
Despite the reduction in packaging efficiency observed
with the 5 UTR deletion vectors, most of the transfer
vectors were successfully transduced into the target cells,
leading to the generation of hygromycin-resistant colonies
(Fig. 2A). However, unlike with packaging, a consistent
loss in the number of Hygr was observed with each incre-
mental deletion of the 5 UTR until none were observed
with TR302, the vector that contains only the PBS (Fig.
2A). Lack of colonies upon transduction of TR302 was
expected since PBS is required for reverse transcription of
the transfer vector RNA, a step critical in vector RNA
propagation. However, loss of the last 53 bp of the 5 UTR
resulted in a big 17  2-fold loss in viral titers (see TR307
and TR309) with the next few deletions reducing viral titers
to an eventual 1340  408-fold in 3- to 6-fold increments
compared to KAL011 (Fig. 2A). These observations suggest
that, in addition to packaging, the 5 UTR deletions also
affected sequences involved with other steps in vector RNA
propagation such as reverse transcription, integration, etc.,
especially the last 53 bp of the 5 UTR.
The first 100 bp of gag are sufficient for efficient RNA
packaging in the presence of the entire 5 UTR
We next determined the role of gag sequences, if any, in
the MPMV RNA encapsidation process. Toward this end,
we created another series of transfer vectors that contained
the entire 5 UTR (128 bp) in the presence of incremental
additions of gag, from 30 bp in TR310 to 797 bp in KAL010
(Fig. 3A). These vectors were tested in the in vivo packag-
ing assay along with the control vector, KAL011.
Analysis of viral particles produced by the packaging
vector, TR301, in each of the transfected cultures revealed
that most of the cultures contained similar levels of viral
particles except cultures expressing TR310, TR314, and
KAL010 (Fig. 3B, panel IV). The reduced expression of the
packaging construct in these cultures correlated with the
lower expression of the respective transfer vectors at the
RNA level (Fig. 3B, panel II), suggesting that the lower
expression of the transfer and packaging constructs was due
to the lower transfection efficiency in these cultures.
Next, we analyzed the amount of RNA packaged by the
virions produced in the transfected Cos cells. These analy-
ses revealed that packaging was substantially reduced when
only 30 bp of gag sequences were present in the transfer
vector (see TR310, panel III, Fig. 3B). Quantitation of the
amount of RNA packaged by TR310 revealed an approxi-
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Fig. 2. The extreme ends of the 5 untranslated region (UTR) of MPMV are critical for efficient packaging of the MPMV genomic RNA in the presence of
gag. (A) MPMV transfer vectors TR302–309 containing varying amounts of 5 UTR in the presence of 284 bp of gag. The virus titers obtained as
colony-forming units per milliliter (CFU/ml) of virus stock posttransduction are indicated to the right along with the fold reduction in titers compared to
KAL011. The value of each titer represents a mean of three independent experiments performed in duplicate along with the standard deviation. No
hygromycin resistant (Hygr) colonies were observed for any of the transfer vectors or packaging and env expression constructs when transfected alone. ,
essentially 100% reduction of viral titers; TNTC, too numerous to count. (B) RNA slot blot and Western blot analyses of virus particles and cellular RNAs
170 R.D. Schmidt et al. / Virology 309 (2003) 166–178
mately threefold loss in RNA packaged by the virions com-
pared to KAL011 when normalized to the intracellular
steady-state levels of transfer vectors RNAs (Fig. 3B, panels
I–III). However, 100 bp of gag restored packaging effi-
ciency to the same level as KAL011 (see TR311, Fig. 3B),
and no further reductions in packaging efficiency were ob-
served with the next four consecutive vectors that contained
from 140 to 797 bp of gag (Fig. 3B). These results clearly
demonstrate that 100 bp of gag are sufficient to confer
efficient RNA packaging on the transfer vectors in the
presence of the entire 5 UTR. In addition, these results also
show that sequences within 797 bp of gag do not harbor any
repressor sequences that affect RNA packaging negatively.
Test of TR310 to KAL010 in the trans-complementation
assay revealed that the packaging efficiency observed with
these vectors overall correlated well with the transduction
efficiency after normalization of the viral titers with the
amount of virus particles produced (see Materials and meth-
ods). These analyses revealed that presence of 30 bp of gag
led to a fourfold loss in viral titers compared to KAL011
(Fig. 3A). It was not until the addition of 100 bp of gag that
the transduction efficiency was restored to within twofold of
KAL011 and remained within 1- to 2.5-fold of KAL011
with the remaining vectors that contained from 140 to 797
bp of gag (Fig. 3A). These results demonstrate that 100 bp
of gag in the presence of the entire 5 UTR are sufficient not
only for efficient packaging, but also for efficient transduc-
tion to the target cells.
MPMV contains a primary packaging determinant
immediately downstream of the PBS whose function is
affected by sequences at the 5 UTR/gag boundary
So far, the data presented in Figs. 2 and 3 have demon-
strated that the first 15 bp immediately downstream of the
PBS and the last 23 bp of the 5 UTR as well as the first 100
bp in gag are important for efficient RNA encapsidation in
MPMV. However, the relative contribution and role of these
sequences to packaging was not clear. Therefore, we ana-
lyzed the requirements of sequences within the 5 UTR and
gag independently of one another. Toward this end, we
generated another series of transfer vectors, TR315–323,
that contained deletions in the 5 UTR in 15-bp increments,
but in the absence of any gag sequences (Fig. 4A). These
vectors were tested in the in vivo packaging and transduc-
tion assay as described before.
Slot blot analysis of RNA packaged from TR323 re-
vealed that in the absence of gag, but in the presence of the
entire 5 UTR, there was a 7.5-fold reduction in packaging
efficiency compared to KAL011, after normalization with
the intracellular steady-state levels of transfer vector RNAs
(Fig. 4B, panels I–III). This suggested that sequences in gag
affected packaging, as shown earlier (Fig. 3). A slightly
improved packaging efficiency, in the absence of gag, was
observed with the next two vectors that contained deletions
of the last 23 and 38 bp of the 5 UTR, respectively (see
TR321 and 322, Fig. 4B). This was unexpected since loss of
the last 23 bp of the 5 UTR, in the presence of gag, had
resulted in a 6.1-fold reduction in packaging efficiency
(TR309, Fig. 2B). Interestingly, the packaging efficiency
was restored essentially to that of KAL011 with further
deletions of the next 45 bp (see TR318–319, Fig. 4B), and
in fact, was enhanced somewhat by an additional 15 bp
deletion in TR317 (Fig. 4B). This observation suggested
that in the absence of gag, part or all of the sequences
between 30 and 90 bp of the 5 UTR negatively affected the
proper folding of the 5 UTR, while shortening of the region
restored the folding potential such that the packaging signal
could function efficiently. This inhibitory effect on the for-
mation of the upstream packaging determinant was not
apparent in the presence of gag sequences (Fig. 2). Thus,
gag sequences seem to be important in stabilizing the for-
mation of the upstream packaging determinant.
Further incremental deletions of 30 bp downstream of
the PBS in the next two vectors resulted in the loss of
packaging efficiency by nearly ninefold compared to
KAL011 (see TR315 and 316, Fig. 4B). A similar observa-
tion was made with TR302 and TR303, vectors that contain
the same 5 UTR deletions as TR315 and 316, but in the
presence of gag in which the packaging efficiency was
reduced by 10- and 7.6-fold, respectively, compared to
KAL011 (Fig. 2B).
Together, results from the deletion analysis of the 5
UTR in the absence of gag sequences confirm our earlier
observations that the two ends of the 5 UTR are important
for efficient packaging in MPMV. The primary packaging
determinant seems to reside within the 30 bp immediately
downstream of the PBS, deletion of which maximally af-
fects packaging efficiency. A complete restoration of the
packaging efficiency in the absence of gag and the last 98
bp of the 5 UTR further reveals that the downstream
sequences shown to affect packaging earlier (last 23 bp of
the 5 UTR and 100 bp of gag) do not per se form the
packaging signal, but probably affect the formation and/or
isolated from Cos cells transfected with the various transfer vectors along with the packaging (TR301) and env (MD.G) expression constructs from one
representative experiment. The RNAs were DNase-treated, diluted, and subjected to slot blot analysis. Panel I represents a 1:2 dilution of 0.5 g of cellular
RNA (0.5, 0.25, and 0.125 g) probed with a fragment of a housekeeping gene, -actin, while panel II represents a 1:3 dilution of 2 g of cellular RNA
(2, 0.67, and 0.22 g) probed with a fragment of the hygromycin gene. Panel III represents a 1:2 dilution of purified virion RNA isolated from the equivalent
of a three-fourth portion of 9 ml media containing virus particles, also probed with a fragment of the hygromycin gene. The column to the right of panel III
refers to the fold reduction in packaging efficiency relative to KAL011 after normalization for RNA loading and transfection efficiency. Panel IV shows
Western blot analysis of equivalent amounts of the remaining one-fourth portion of the purified virions harvested from each of the transfected cultures in the
corresponding trans-complementation assay using MPMV Gag/Pol polyclonal antiserum. Mock, cells transfected without DNA.
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Fig. 3. The first 100 bp in gag are sufficient for efficient packaging of the MPMV genomic RNA in the presence of the entire 5 UTR. (A) MPMV transfer
vectors TR310–314 containing varying amounts of gag sequences. The virus titers were obtained as colony-forming units per milliliter (CFU/ml) of virus
172 R.D. Schmidt et al. / Virology 309 (2003) 166–178
stability of the primary packaging determinant. Thus, simul-
taneous deletion of the primary and secondary determinants
in TR315 (Fig. 4B) reduces the packaging efficiency to
similar levels (ninefold) as deletion of the secondary deter-
minant alone (TR323, 7.5-fold, Fig. 4B or TR302, 10-fold,
Fig. 2B).
Finally, the transduction efficiency of TR315–323 was
analyzed in the in vivo transduction assay. Once again, a
progressive loss in transduction efficiency was observed
with several incremental deletions in the 5 UTR. Presence
of the entire 5 UTR in the absence of gag sequences
resulted in a 36  9-fold loss in viral titers compared to
KAL011 (TR323, Fig. 4A). There was another 10-fold drop
in the transduction efficiency to 355  50-fold with a 23-bp
deletion in the 5 UTR (TR322, Fig. 4A). Part of the decline
in transduction efficiency observed could be attributable to
the reduction in packaging efficiency (7.5- and 4.8-fold,
respectively), while the remaining decline can be attributed
to the loss of cis-acting elements by the deletions that affect
vector RNA propagation.
With further incremental deletions of the subsequent 60
bp in the next four consecutive vectors, TR317–321, the
drastic reduction in the transduction efficiency stabilized to
between 410- and 578-fold compared to KAL011 (Fig. 4A).
This is despite essentially wild-type levels of RNA packag-
ing observed with these vectors except TR321. This sug-
gested that sequences within 30–90 bp from the PBS (de-
leted in TR317–319) did not affect vector RNA
propagation, while they negatively impacted RNA packag-
ing in the absence of gag since their loss resulted in the
return of the packaging efficiency back to the wild-type, as
suggested earlier.
Once again, similar to TR303 and 304 (Fig. 2B), loss of
sequences between 15 and 30 bp downstream from the PBS
resulted in a further reduction in transduction efficiency
from 578  66-fold in TR317 to 3900  1110 in TR316
compared to KAL011 ( a sevenfold drop), while no Hygr
were observed with TR315, the vector that had lost the 15
bp immediately downstream from the PBS. The loss in titers
observed with all the vectors was despite the fact that
similar levels of virions were produced in each of the
transfected cultures (Fig. 4B, panel IV). These data suggest
that the extreme ends of the 5 UTR and beginning of gag
harbor sequences that affect both RNA packaging and vec-
tor RNA propagation.
Discussion
This study used a systematic deletion analysis of the 5
UTR and gag sequences of MPMV to unravel the complex
nature of its packaging determinants. Our results reveal that
sequences important for MPMV packaging are found as two
discrete elements, the first comprising 30 bp immediately
downstream of the PBS, Region I (Fig. 2B), and the other
comprising approximately the last 23 bp of the 5 UTR (Fig.
2B) and the first 100 bp of the gag gene, Region II (Fig. 3B).
Our data further suggest that Region I serves as the primary
packaging determinant of MPMV, while Region II is im-
portant for the formation and/or stability of the primary
packaging determinant (Fig. 4B). This can be observed by
the fact that Regions I and II were quite similar in their
relative contribution toward packaging. Deletion of Region
II (see TR309 in Fig. 2B and TR322 and 323 in Fig. 4B)
resulted in a 5- to 7.5-fold (average 6.25) drop in pack-
aging efficiency compared to a complete deletion of both
Regions I and II, which resulted in a similar 8.7- to 10-fold
(average 9.3) drop in packaging efficiency (see TR302 in
Fig. 2B and TR315 in Fig. 4B). These findings are in
contrast to what we have observed in FIV where of the two
packaging determinants mapped; deletion of either one re-
sulted in a 4- to 6-fold loss in packaging efficiency, while
deletion of the two determinants together reduced packag-
ing efficiency sharply to nearly 40-fold, suggesting syner-
gistic effects of the two regions on packaging (Browning et
al., 2003). Thus, the lack of synergy exhibited by MPMV
packaging determinants versus those of FIV suggests dif-
ferences in the manner in which the two viruses package
their genomes.
These results are understandable given the high propen-
sity of the 5 UTR and gag region of MPMV to fold into a
complex higher order structure (Harrison et al., 1995).
Based on this structure, Region I, encompassing 30 bp from
the PBS, comaps with the first stem loop predicted by
Harrison and colleagues. Similarly, sequences encompass-
ing Region II has been predicted to fold into two stem loops
structures. Our data also suggest that Region II may assume
a higher order structure since deletion of gag sequences
alone or the last 23 bp of the 5 UTR alone were sufficient
to reduce the functionality of Region II for encapsidation
(Figs. 2B and 4B).
As indicated earlier, we find that the region between the
major SD and the Gag initiation codon (encompassed by the
stock posttransduction and were normalized to the virus particles produced as described under Materials and methods. The fold reduction in titers compared
to KAL011 is indicated to the right. The raw values for each titer were obtained from a mean of three independent experiments performed in duplicate along
with the standard deviation. (B) RNA slot blot and Western blot analyses of virus particles and cellular RNAs isolated from Cos cells transfected with the
various transfer vectors as described in the legend to Fig. 2 from one representative experiment. Panels I and II are slot blots of cellular RNAs, while panel
III is a slot blot of virion RNA isolated from transiently transfected Cos cells. The column to the right of panel III refers to the fold reduction in packaging
efficiency relative to KAL011 after normalization for RNA loading and transfection efficiency. The RNAs were DNase treated and subjected to slot blot
analysis as mentioned in the legend to Fig. 2. Panel IV shows Western blot analysis of purified virions harvested from each of the transfected cultures as
described under Materials and methods. Mock, cells transfected without DNA.
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Fig. 4. The MPMV packaging signal is composed of two redundant packaging elements both of which are required for efficient RNA packaging. (A)
Schematic representation of the MPMV transfer vectors TR315–323 containing varying amounts of 5 UTR in the absence of gag sequences. The virus titers
obtained as colony-forming units per milliliter (CFU/ml) of virus stock posttransduction are indicated to the right along with the fold reduction in titers
compared to KAL011. The value of each titer represents a mean of three independent experiments performed in duplicate along with the standard deviation.
(B) RNA slot blot and Western blot analyses of virus particles and cellular RNAs isolated from Cos cells transfected with the various transfer constructs as
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last 23 bp of the 5 UTR) is important for packaging (Fig.
2B). This is in contrast to the deletion analysis of Guesdon
et al., who did not see a role of this region in packaging.
According to their analysis, a 61-bp deletion upstream of the
SD reduced MPMV RNA packaging by about twofold
(58%), but not an 11-bp deletion downstream of the SD
(Guesdon et al., 2001). The difference in the results of the
two studies could be due to several reasons. One reason
could be that, as our analysis indicates, the role of this
region in packaging is more indirect, affecting the formation
and/or stability of the primary packaging determinant lo-
cated in Region I. Thus, the 11-bp deletion introduced by
Guesdon et al. may not have been sufficiently large enough
to have disrupted Region II and its ability to affect the
packaging potential of the primary packaging determinant
located in Region I. Another reason could be that Guesdon
et al. used a replication-competent virus for the analysis of
their deletion mutations. It is well known that use of a
replication-competent virus leads to multiple rounds of rep-
lication that can mask effects of mutations that are not very
pronounced or exaggerate the effects of mutations that may
not be very significant. Our system used a single round of
replication assay in which even minor effects of the muta-
tion should be easily identifiable. In fact, our study indicates
that the 61-bp deletion that Guesdon et al. found important
in packaging is not essential for packaging in our system.
Guesdon and colleagues have earlier predicted this 61-bp
region to fold into the stable, conserved, stem loop 4 that
contains a GC-rich stem that is found upstream of the SD
(Harrison et al., 1995). In fact, site-directed mutagenesis
designed to destabilize this stem loop in various ways or
introduction of compensatory mutations to reform the mu-
tated stem loop has also revealed that stem loop 4 does not
seem to affect RNA packaging significantly in MPMV
(Lew, K.A., Mustafa, F., Schmidt, R.D., Browning, M.T.,
and Rizvi, T.A., unpublished observations).
Our trans-complementation assay, in addition to assess-
ing the role of the mutations on packaging, also provided
information on the effect of these mutations on the ability of
the vector RNAs to be propagated to the target cells. Anal-
ysis of the consequence of the deletions on vector RNA
propagation revealed that overall loss in vector RNA titer
was observed with each consecutive deletion in the 5 UTR.
However, the terminal 23 bp of the 5 UTR and sequences
near the PBS had a more dramatic effect than sequences
within the middle region of the 5 UTR. Furthermore, the
effect of these mutations on vector RNA propagation was
more drastic in the absence of gag than in its presence (Figs.
2A and 4A). This suggests that gag sequences may have a
stabilizing role on 5 UTR sequences that affect vector RNA
propagation. On the other hand, gag may also contain ad-
ditional sequences that positively affect other steps of the
retroviral life cycle.
In summary, a detailed deletion analysis of sequences
within the 5 end of the MPMV genome reveals the pres-
ence of a primary packaging determinant immediately
downstream of the PBS whose function is dependent upon
the presence of sequences within the 5 UTR and the gag
boundary. Information obtained from the analysis of these
packaging determinants should be valuable in the develop-
ment of improved retroviral vectors for the elucidation of
basic steps in the replication of the type D retroviruses as
well as the development of safer, more efficient retroviral
vectors for gene therapy.
Materials and methods
Numbering system
Nucleotide designations for MPMV are based on Gen-
Bank Accession No. M12349.
Plasmid construction
MPMV packaging construct and envelope expression vector
The MPMV packaging construct TR301 has been de-
scribed before (Browning et al., 2001) (Fig. 1A). TR301
expresses the gag/pol genes from the CMV/intron A/pro-
moter/enhancer, contains MPMV CTE, and uses the BGH
poly(A) sequences for transcript termination. The VSV-G
envelope expression vector, MD.G, was obtained from Dr.
Didier Trono and has been described before (Naldini et al.,
1996) (Fig. 1B).
KAL010 and KAL011
KAL010 (Fig. 3B) and KAL011 (Fig. 1C) are MPMV
transfer vectors constructed from KAL006 and KAL007
and contain 284 and 797 bp of gag gene downstream of the
entire MPMV 5 UTR. KAL006 and KAL007 themselves
were derived from the MPMV genomic construct, KAL001,
that has been described before (Rizvi et al., 1996b).
KAL006 contains MPMV sequences from the 5 LTR to nt
1687 of gag, while KAL007 contains MPMV sequences
from the 5 LTR to nt 1172 of gag. At the 3 end, both
KAL006 and KAL007 contain MPMV sequences from nt
7181 to the end of the 3 LTR. These plasmids were con-
structed by deleting all viral sequences between either nt
described in the legend to Fig. 2 from one representative experiment. Panels I and II are slot blots of cellular RNAs, while panel III is slot blot of virion RNA
isolated from transiently transfected Cos cells. The column to the right of panel III refers to the fold reduction in packaging efficiency relative to KAL011
after normalization for RNA loading and transfection efficiency. The RNAs were DNase-treated, diluted, and subjected to slot blot analysis as mentioned in
the legend to Fig. 2. Panel IV shows Western blot analysis of purified virions harvested from each of the transfected cultures as described under Materials
and methods. Mock, cells transfected without DNA. *, sample lost.
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1687 or nt 1172 and 7181, followed by a simultaneous
insertion of a NheI linker at the point of deletion. A SV-
Hygr cassette with flanking NheI sites was inserted in the
correct orientation at the site of the NheI linker insertion to
create KAL010 and KAL011, respectively.
5 UTR deletion vectors in the presence of gag
sequences
TR302–309 (Fig. 2A) are MPMV transfer vectors that
contain deletions in the 5 UTR in 15-bp increments from
the start of gag to the end of the PBS in the presence of 284
bp of gag sequences. These vectors were generated via PCR
amplification of fragments of the 5 UTR using a derivative
of KAL001, KAL048, as a template. KAL048 is a MPMV
transfer vector that contains all viral sequences other than a
deletion at the 3 end of the viral genome encompassing the
end of env and the MPMV CTE (Rizvi et al., 1996b). The
PCR used sense (S) oligonucleotide OpIC19H (ATGAC-
CATGATTAcgccaag) that corresponds to sequences up-
stream of the 5 UTR in the cloning vector pIC19H that was
used to create KAL048 and individual antisense (A) oligo-
nucleotides listed below (uppercase for MPMV sequences
while lowercase for NheI site introduced for cloning pur-
poses):
TR302 OTR184 (AS; 5 cccgctagcGCCCCAGCTTGGGCG
3; nt 761–747)
TR303 OTR185 (AS; 5 cccgctagcATTCCCTCGTATCCA
3; nt 776–762)
TR304 OTR186 (AS; 5 cccgctagcCGTCTTCCTCACGAA
3; nt 791–777)
TR305 OTR187 (AS; 5
cccgctagcGGCCGGCGAACGCGT 3; nt 806–792)
TR306 OTR188 (AS 5 cccgctagcTCACTTTTAATCGCC
3, nt 821–807)
TR307 OTR189 (AS 5 cccgctagcCAAGAGAGTTTACTT
3, nt 836–837)
TR308 OTR 190 (AS 5 cccgctagcGGTTCCCGCGGCGGC
3, nt 851–837)
TR309 OTR191 (AS 5 cccgctagcAGGTCCAACGCGGCA
3, nt 866–852)
The PCR products were digested with SalI and NheI
and cloned into the XhoI and NheI sites of KAL011,
creating subclones that lacked any gag sequences, the
SV-Hygr cassette, or CTE. Next, KAL007 was used as
the template to reintroduce MPMV gag sequences be-
tween 890 and 1172 and env sequences between 7181 and
7578 by PCR using oligonucleotides OTR195 (S; 5
ggactagtATGGGGCAAGAATTAAGC 3; nt 890 –907)
and OTR144 (AS; 5 ACGGCTCCGGACATGAGA-
TCTTGTATAGTGCTA GAA 3; nt 8219 – 8205 fol-
lowed by nt 7578 –7558). The PCR products were di-
gested with SpeI and BglII and ligated to the NheI and
BglII sites of the subclones. Finally, the SV-Hygr cassette
was reinserted at the NheI site created by PCR down-
stream of the gag sequences to generate TR302–309.
MPMV transfer vectors with incremental insertions of gag
to the 5 UTR
TR310–314 are MPMV transfer vectors that contain the
entire 5 UTR juxtaposed to varying amounts of gag se-
quences from 0 to 220 bp. These vectors were created in a
manner very similar to the above vectors except that the
entire 5 UTR was amplified along with incremental addi-
tions of gag. The PCR was performed as before using
KAL048 as the template and OpIC19H as the sense oligo-
nucleotide, while the antisense oligonucleotides used were
as follows:
TR310 OTR193 (AS; 5 cccgctagcAACGTTCATGCTGGC
3; nt 920–906)
TR311 OTR196 (AS; 5 cccgctagcAATTTCAAAAGATCA
3; nt 990–976)
TR312 OTR197 (AS; 5 cccgctagcTTGCGGAAACCAAGG
3; nt 1030–1016)
TR313 OTR198 (AS; 5 cccgctagcCGCCTACTCGACGCC
3; nt 1070–1056)
TR314 OTR199 (AS; 5 cccgctagcTTCTCCGGGCCAAAA
3; nt 1110–1096)
The PCR fragments obtained were digested and cloned using
the several stages of cloning as described above to generate
the final constructs.
5 UTR deletion vectors in the absence of gag sequences
TR315–323 are MPMV transfer vectors that contain the
same 5 UTR deletions described for TR302–309, but in the
absence of gag sequences. The deletions were created by
PCR using the sense oligonucleotide OpIC19H and anti-
sense oligonucleotides OTR185–191 as described above
and KAL048 as the template. The PCR products were di-
gested with SalI and NheI and cloned into the XhoI and NheI
sites of KAL011 as before with the reinsertion of the SV-
Hygr cassette at the NheI site, creating the final vectors.
All PCR amplifications were performed using the Per-
kin–Elmer 9600 thermocycler with MicroAmp tubes as de-
scribed before (Browning et al., 2001).
Transfections and infections of cells
Cos cells were maintained at 37°C in Dulbecco’s mod-
ified Eagle’s medium (DMEM) supplemented with 10%
fetal bovine serum from Hyclone (Logan, UT). HeLa CD4
cells were maintained in DMEM supplemented with 7%
calf serum from Hyclone. Transfections of Cos cells and
infections of HeLa CD4 cells have been described before
(Browning et al., 2001).
Western and slot blot analyses
Virus particles were harvested from 9 ml of clarified
tissue culture supernatants as described earlier (Browning et
al., 2001). Virus particles were resuspended in 100 l of
TNE buffer (50 mM Tris–Cl, pH 7.4, 100 mM NaCl, and 1
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mM EDTA, pH 8.0) of which 25 l was used for protein
extraction, while the remaining 75 l was used to isolate
virion RNA. Viral proteins were analyzed by Western blot
analysis using the Enhanced Chemiluminescence kit (Am-
ersham, Arlington Heights, IL) as described before (Rizvi et
al., 1997). The anti-MPMV Gag/Pol Pr78 polyserum was
kindly provided by Dr. Eric Hunter (University of Alabama,
Birmingham, AL).
Viral RNA was isolated from the pelleted viral particles
and transfected Cos cells as described before (Browning et
al., 2001). Both viral and cellular RNAs were treated with
RNase-free DNase to eliminate any contaminating DNA
and blotted on slot blots for analysis as described before
(Rizvi et al., 1996b, 1997). The filters were hybridized with
either a hygromycin gene-specific DNA probe or a -actin
cDNA probe (Clontech, Palo Alto, CA) as described earlier
(Rizvi et al., 1996b).
Normalization of packaging and transduction efficiencies
Normalization of packaging efficiency was performed
briefly as follows: band intensities in the slot blots were
estimated by scanning the autoradiographs electronically
and using the Multi Analyst software (version 1.1) from
Bio-Rad Laboratories (Hercules, CA) for measuring optical
densities. Background densities observed in mock transfec-
tions were first subtracted from test values followed by
normalization of each value with the background-subtracted
values obtained from the control vector, KAL011. Subse-
quently, values obtained from the three dilutions of each





where A  average of amount of RNA packaged into
virions, as observed in panel III of slot blots (after subtrac-
tion of background and normalization with KAL011), B 
average of amount of cellular RNA loaded, as observed in
panel I of slot blots (after normalization with KAL011), and
C  average of amount of transfer vector RNA expressed,
as observed in panel II of slot blots (after subtraction of
background and normalization with KAL011).
Finally, the fold reduction in packaging efficiency was
obtained by dividing the packaging efficiency obtained for
each construct with that of KAL011.
Similarly, in Fig. 3, viral titers were normalized to the
amount of particles produced by first measuring the optical
densities observed in the Western blots of virus particles
and dividing with that observed for KAL011 after subtrac-
tion of background. Next, the titers observed were divided
by the factor obtained to calculate the normalized viral
titers. Finally, fold reduction in viral titers was obtained by
dividing the normalized viral titers with that observed for
KAL011.
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